Skip to main content
. 2022 Nov 23;10:1071464. doi: 10.3389/fped.2022.1071464

Figure 5.

Figure 5

Renal clearance for 1,5-anhydroglucitol and glucose before and during EMPA treatment for PT2. Renal clearance of 1,5-AG increases in parallel to the glucose clearance in 24-hr urine collections for PT2, indicating that glucosuria prevents the renal uptake of 1,5-AG and results in its urinary excretion.